根据瘤大小和形状个性化的自动格子辐射疗法治疗计划
Mathieu Gaudreault1, Kelvin K Yu2, David Chang3
1Department of Physical Sciences, Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia; Sir Peter MacCallum, Department of Oncology, the University of Melbourne, Victoria 3000, Australia.
概括
一种用于晶格辐射疗法 (LRT) 计划的自动化方法优化了对瘤的治疗. 这种方法将格子几何形状定制为瘤形状,改善剂量均性和异质性.
科学领域:
- 辐射瘤学 辐射瘤学
- 医学物理 医学物理
- 计算生物学 计算生物学
背景情况:
- 格子辐射疗法 (LRT) 通过交替高剂量和低剂量区域提供了改善瘤控制的潜力.
- 对于LRT的最佳格子参数仍未得到充分探索,这阻碍了其广泛的临床应用.
- 个性化治疗规划对于最大限度地提高治疗疗效和最大限度地降低毒性至关重要.
研究的目的:
- 引入一个自动化的格子辐射疗法规划方法.
- 根据个体瘤形状来个性化格子几何.
- 为了促进对最佳格子参数的调查,以改善治疗结果.
主要方法:
- 使用 Eclipse 脚本应用程序接口开发了一个自动化的 LRT 计划系统.
- 在总瘤体积 (GTV) 中,通过交替方形模式,代确定顶点大小和中心到中心距离.
- 评估了40个基于GTV剂量统一性,异质性和危险器官节省的格子配置.
主要成果:
- 包括50名患有逆皮质肉瘤的患者 (瘤体积为150-10,000厘米3).
- 确定了最佳格子参数:V = 0.19 (GTV体积) 1/3和D = 2V (厘米).
- 推导出一个公式来估计治疗规划所需的顶点数 (N).
结论:
- 开发的自动化LRT规划方法可以根据瘤大小进行个性化治疗.
- 这种方法促进了对格子几何优化的全面调查.
- 这些发现为完善LRT协议和改善患者治疗结果提供了基础.
相关概念视频
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.